دورية أكاديمية

Case Report: Nontuberculous mycobacterial infections in children with complete DiGeorge anomaly

التفاصيل البيبلوغرافية
العنوان: Case Report: Nontuberculous mycobacterial infections in children with complete DiGeorge anomaly
المؤلفون: Elizabeth Daly Hicks, Noah O. Agada, Tyler R. Yates, Matthew S. Kelly, Jonathan S. Tam, Ronald M. Ferdman, Louis R. Dibernardo, John F. Madden, M. Anthony Moody, Mary Louise Markert
المصدر: Frontiers in Immunology, Vol 14 (2023)
بيانات النشر: Frontiers Media S.A., 2023.
سنة النشر: 2023
المجموعة: LCC:Immunologic diseases. Allergy
مصطلحات موضوعية: athymia, complete DiGeorge syndrome, DiGeorge anomaly, nontuberculous mycobacteria, Mycobacterium kansasii, Mycobacterium avium complex, Immunologic diseases. Allergy, RC581-607
الوصف: Children with complete DiGeorge anomaly (cDGA) have congenital athymia, resulting in severe T cell immunodeficiency and susceptibility to a broad range of infections. We report the clinical course, immunologic phenotypes, treatment, and outcomes of three cases of disseminated nontuberculous mycobacterial infections (NTM) in patients with cDGA who underwent cultured thymus tissue implantation (CTTI). Two patients were diagnosed with Mycobacterium avium complex (MAC) and one patient with Mycobacterium kansasii. All three patients required protracted therapy with multiple antimycobacterial agents. One patient, who was treated with steroids due to concern for immune reconstitution inflammatory syndrome (IRIS), died due to MAC infection. Two patients have completed therapy and are alive and well. T cell counts and cultured thymus tissue biopsies demonstrated good thymic function and thymopoiesis despite NTM infection. Based on our experience with these three patients, we recommend that providers strongly consider macrolide prophylaxis upon diagnosis of cDGA. We obtain mycobacterial blood cultures when cDGA patients have fevers without a localizing source. In cDGA patients with disseminated NTM, treatment should consist of at least two antimycobacterial medications and be provided in close consultation with an infectious diseases subspecialist. Therapy should be continued until T cell reconstitution is achieved.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1664-3224
العلاقة: https://www.frontiersin.org/articles/10.3389/fimmu.2023.1078976/fullTest; https://doaj.org/toc/1664-3224Test
DOI: 10.3389/fimmu.2023.1078976
الوصول الحر: https://doaj.org/article/e371aef595714601ae24b1d9edcb83d4Test
رقم الانضمام: edsdoj.371aef595714601ae24b1d9edcb83d4
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:16643224
DOI:10.3389/fimmu.2023.1078976